My NCBI | Sign In
RSS Settings
  • Search:

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 207

    1.

    Histologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapy.

    Shiratori Y, Imazeki F, Moriyama M, Yano M, Arakawa Y, Yokosuka O, Kuroki T, Nishiguchi S, Sata M, Yamada G, Fujiyama S, Yoshida H, Omata M.

    Ann Intern Med. 2000 Apr 4;132(7):517-24.PMID: 10744587 [PubMed - indexed for MEDLINE]Related articlesFree article

    2.

    Interferon therapy reduces the risk for hepatocellular carcinoma: national surveillance program of cirrhotic and noncirrhotic patients with chronic hepatitis C in Japan. IHIT Study Group. Inhibition of Hepatocarcinogenesis by Interferon Therapy.

    Yoshida H, Shiratori Y, Moriyama M, Arakawa Y, Ide T, Sata M, Inoue O, Yano M, Tanaka M, Fujiyama S, Nishiguchi S, Kuroki T, Imazeki F, Yokosuka O, Kinoyama S, Yamada G, Omata M.

    Ann Intern Med. 1999 Aug 3;131(3):174-81.PMID: 10428733 [PubMed - indexed for MEDLINE]Related articlesFree article

    3.

    Sustained virologic response and clinical outcomes in patients with chronic hepatitis C and advanced fibrosis.

    Veldt BJ, Heathcote EJ, Wedemeyer H, Reichen J, Hofmann WP, Zeuzem S, Manns MP, Hansen BE, Schalm SW, Janssen HL.

    Ann Intern Med. 2007 Nov 20;147(10):677-84.PMID: 18025443 [PubMed - indexed for MEDLINE]Related articlesFree article

    4.

    Changes of liver fibrosis in chronic hepatitis C patients with no response to interferon-alpha therapy: including quantitative assessment by a morphometric method.

    Yagura M, Murai S, Kojima H, Tokita H, Kamitsukasa H, Harada H.

    J Gastroenterol. 2000;35(2):105-11.PMID: 10680665 [PubMed - indexed for MEDLINE]Related articles

    5.

    Interferon treatment improves survival in chronic hepatitis C patients showing biochemical as well as virological responses by preventing liver-related death.

    Kasahara A, Tanaka H, Okanoue T, Imai Y, Tsubouchi H, Yoshioka K, Kawata S, Tanaka E, Hino K, Hayashi K, Tamura S, Itoh Y, Kiyosawa K, Kakumu S, Okita K, Hayashi N.

    J Viral Hepat. 2004 Mar;11(2):148-56.PMID: 14996350 [PubMed - indexed for MEDLINE]Related articles

    6.

    Eradication of hepatitis C virus in patients successfully treated for chronic hepatitis C.

    Maylin S, Martinot-Peignoux M, Moucari R, Boyer N, Ripault MP, Cazals-Hatem D, Giuily N, Castelnau C, Cardoso AC, Asselah T, Féray C, Nicolas-Chanoine MH, Bedossa P, Marcellin P.

    Gastroenterology. 2008 Sep;135(3):821-9. Epub 2008 May 21.PMID: 18593587 [PubMed - indexed for MEDLINE]Related articles

    7.

    The rate of fibrosis progression is an independent predictor of the response to antiviral therapy in chronic hepatitis C.

    Myers RP, Patel K, Pianko S, Poynard T, McHutchison JG.

    J Viral Hepat. 2003 Jan;10(1):16-22.PMID: 12558907 [PubMed - indexed for MEDLINE]Related articles

    8.

    Sustained viral response to interferon and ribavirin in liver transplant recipients with recurrent hepatitis C.

    Abdelmalek MF, Firpi RJ, Soldevila-Pico C, Reed AI, Hemming AW, Liu C, Crawford JM, Davis GL, Nelson DR.

    Liver Transpl. 2004 Feb;10(2):199-207.PMID: 14762857 [PubMed - indexed for MEDLINE]Related articlesFree article

    9.

    Interferon therapy prolonged life expectancy among chronic hepatitis C patients.

    Yoshida H, Arakawa Y, Sata M, Nishiguchi S, Yano M, Fujiyama S, Yamada G, Yokosuka O, Shiratori Y, Omata M.

    Gastroenterology. 2002 Aug;123(2):483-91.PMID: 12145802 [PubMed - indexed for MEDLINE]Related articles

    10.

    Long-term liver histology improvement in patients with chronic hepatitis C and sustained response to interferon.

    Toccaceli F, Laghi V, Capurso L, Koch M, Sereno S, Scuderi M; Italian Hepanet Group.

    J Viral Hepat. 2003 Mar;10(2):126-33.PMID: 12614469 [PubMed - indexed for MEDLINE]Related articles

    11.

    Favorable prognosis of chronic hepatitis C after interferon therapy by long-term cohort study.

    Imazeki F, Yokosuka O, Fukai K, Saisho H.

    Hepatology. 2003 Aug;38(2):493-502.PMID: 12883494 [PubMed - indexed for MEDLINE]Related articles

    12.

    Brief communication: the relationship of regression of cirrhosis to outcome in chronic hepatitis C.

    Mallet V, Gilgenkrantz H, Serpaggi J, Verkarre V, Vallet-Pichard A, Fontaine H, Pol S.

    Ann Intern Med. 2008 Sep 16;149(6):399-403. Erratum in: Ann Intern Med.2008 Dec 2;149(11):844. PMID: 18794559 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    Long-term histological prognosis and serum fibrosis markers in chronic hepatitis C patients treated with interferon.

    Kojima H, Hongo Y, Harada H, Inoue T, Miyaji K, Kashiwagi M, Momose T, Arisaka Y, Fukui H, Murai S, Tokita H, Kamitsukasa H, Yagura M, Katsu K.

    J Gastroenterol Hepatol. 2001 Sep;16(9):1015-21.PMID: 11595066 [PubMed - indexed for MEDLINE]Related articles

    14.

    Natural course of asymptomatic hepatitis C virus-infected patients and hepatocellular carcinoma after interferon therapy.

    Okanoue T, Minami M, Makiyama A, Sumida Y, Yasui K, Itoh Y.

    Clin Gastroenterol Hepatol. 2005 Oct;3(10 Suppl 2):S89-91.PMID: 16234069 [PubMed - indexed for MEDLINE]Related articles

    15.

    Long term histological improvement and clearance of intrahepatic hepatitis C virus RNA following sustained response to interferon-ribavirin combination therapy in liver transplanted patients with hepatitis C virus recurrence.

    Bizollon T, Ahmed SN, Radenne S, Chevallier M, Chevallier P, Parvaz P, Guichard S, Ducerf C, Baulieux J, Zoulim F, Trepo C.

    Gut. 2003 Feb;52(2):283-7.PMID: 12524414 [PubMed - indexed for MEDLINE]Related articlesFree article

    16.

    Liver stellate cells and aminoterminal peptide of type III procollagen in chronic hepatitis C treated with interferon.

    Gabrielli GB, Casaril M, Stanzial AM, Colombari R, Pasino M, Corrocher R.

    Hepatogastroenterology. 2003 Nov-Dec;50(54):2017-21.PMID: 14696456 [PubMed - indexed for MEDLINE]Related articles

    17.

    Sustained virological response following HCV therapy is associated with non-progression of liver fibrosis in HCV/HIV-coinfected patients.

    Barreiro P, Labarga P, Martín-Carbonero L, Amor A, Ruiz-Sancho A, Castellares C, González-Lahoz J, Soriano V.

    Antivir Ther. 2006;11(7):869-77.PMID: 17302249 [PubMed - indexed for MEDLINE]Related articles

    18.

    Regression of fibrosis in chronic hepatitis C after therapy with interferon and ribavirin.

    Arif A, Levine RA, Sanderson SO, Bank L, Velu RP, Shah A, Mahl TC, Gregory DH.

    Dig Dis Sci. 2003 Jul;48(7):1425-30.PMID: 12870807 [PubMed - indexed for MEDLINE]Related articles

    19.

    Modeling the impact of interferon alfa treatment on liver fibrosis progression in chronic hepatitis C: a dynamic view. The Multivirc Group.

    Sobesky R, Mathurin P, Charlotte F, Moussalli J, Olivi M, Vidaud M, Ratziu V, Opolon P, Poynard T.

    Gastroenterology. 1999 Feb;116(2):378-86.PMID: 9922319 [PubMed - indexed for MEDLINE]Related articles

    20.

    Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation.

    Stravitz RT, Shiffman ML, Sanyal AJ, Luketic VA, Sterling RK, Heuman DM, Ashworth A, Mills AS, Contos M, Cotterell AH, Maluf D, Posner MP, Fisher RA.

    Liver Transpl. 2004 Jul;10(7):850-8.PMID: 15237368 [PubMed - indexed for MEDLINE]Related articlesFree article

    Supplemental Content

    Filter your results:

    Find related data

    Recent activity